Latest Earnings Results: Q3 '26
Estimated EPS
-$0.24
Reported EPS
-$0.20
Surprise
+16.46%
Estimated Rev
$22.35M
Reported Rev
$26.11M
Surprise
+16.84%
• Reported GAAP EPS of -$0.20 up 56.52% YoY • Reported revenue of $26.11M up 53.05% YoY • AVITA Medical raised full-year 2026 revenue guidance to $92M to $94M from $86M to $89M and reaffirmed cash flow breakeven expectation in Q4 2026.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.14 | -- | -- | N/A |
Q3 '26 | -$0.24 | -$0.20 | 16.46% | BEAT |
Q2 '26 | -$0.29 | -$0.25 | 14.62% | BEAT |
Q1 '26 | -$0.29 | -$0.35 | -19.86% | MISSED |
Q4 '25 | -$0.36 | -$0.38 | -4.27% | MISSED |